Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Peptides for Low Libido Research: Mechanism Comparison

Researchers investigating peptides for low libido applications need to match the compound's mechanism to the suspected pathway dysfunction. This table compares the primary peptides studied for libido modulation, their receptor targets, onset characteristics, a

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Researchers investigating peptides for low libido applications need to match the compound's mechanism to the suspected pathway dysfunction. This table compares the primary peptides studied for libido modulation, their receptor targets, onset characteristics, and the biological pathways they address.
  • PT-141 (Bremelanotide)
  • Melanocortin-4 receptor (MC4R)
  • 30–60 minutes
  • 2.7 hours
  • Central nervous system arousal signaling, independent of sex hormones
  • Best for research models where libido is suppressed despite normal testosterone/estrogen levels; works through desire circuitry rather than hormone replacement
  • Kisspeptin-10
  • GPR54 (KISS1R)
  • 30–60 minutes (LH elevation)
  • 28 minutes
  • Hypothalamic-pituitary-gonadal axis; stimulates endogenous LH/FSH and gonadal steroidogenesis
  • Ideal for investigating secondary hypogonadism and HPG axis dysfunction; restores endogenous hormone production rather than replacing it exogenously
  • Oxytocin
  • Oxytocin receptor (OXTR)
  • 30–45 minutes (intranasal)
  • 7 minutes (plasma), 60–90 minutes (CNS effect)
  • Parasympathetic activation, limbic bonding circuits, anxiety reduction
  • Most effective for libido suppression driven by anxiety, stress, or emotional disconnection; enhances trust and intimacy signaling
  • Melanotan II
  • MC1R, MC4R (non-selective)
  • 60–90 minutes
  • 33 minutes
  • Melanocortin system (broader agonism than PT-141)
  • Non-selective MC receptor agonism produces more side effects than PT-141; used in research settings where MC1R effects (skin pigmentation) are being studied alongside MC4R arousal effects